Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envirocleanse LLC, a subsidiary of Charter Brokerage and part of the Berkshire Hathaway family of companies, is a healthcare technology and environmental services firm specializing in electrochemical activation (ECA) technology. The company produces Envirocleanse-A, a non-toxic, pH-neutral hypochlorous acid (HOCl) solution that serves as a highly effective disinfectant and sanitizer across medical, industrial, and maritime sectors. Their technology is utilized for high-level surface disinfection in healthcare facilities, wound care management, and ballast water treatment systems. Envirocleanse focuses on providing sustainable, biodegradable alternatives to traditional chemical disinfectants like bleach and quaternary ammonium. The company's solutions are EPA-registered and designed to eliminate a broad spectrum of bacteria, viruses, and spores without the corrosive or irritant properties of standard cleaners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envirocleanse.